Back to Search Start Over

Effectiveness of COVID-19 vaccination against school absenteeism in children and adolescents hospitalized with COVID-19.

Authors :
Maltezou HC
Kontogianni S
Michailidou E
Vergadi E
Giannouchos TV
Steletou E
Sipsas NV
Galanakis E
Syrogiannopoulos GA
Roilides E
Source :
Vaccine [Vaccine] 2024 Apr 30; Vol. 42 (12), pp. 2941-2944. Date of Electronic Publication: 2024 Mar 30.
Publication Year :
2024

Abstract

Background: COVID-19 vaccination has been recommended for children to protect them and to enable in-person educational and social activities.<br />Methods: We estimated COVID-19 vaccination effectiveness (VE) against school absenteeism in children 5-17 years old hospitalized from September 1, 2021 through May 31, 2023. Full vaccination was defined as two vaccine doses.<br />Results: We studied 231 children admitted to hospital with COVID-19, including 206 (89.2 %) unvaccinated/partially vaccinated and 25 (10.8 %) fully vaccinated. Unvaccinated/partially vaccinated children were absent from school for longer periods compared to fully vaccinated children (median absence: 14 versus 10 days; p-value = 0.05). Multivariable regression showed that full COVID-19 vaccination was associated with fewer days of absence compared to no/partial vaccination on average (adjusted relative risk: 0.77; 95 % CI: 0.61 to 0.98). COVID-19 VE was 50.7 % (95 % CI: -11.3 % to 78.2 %) for school absenteeism above the median duration of absenteeism.<br />Conclusions: Full COVID-19 vaccination conferred protection against school absenteeism in hospitalized school-aged children with COVID-19.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1873-2518
Volume :
42
Issue :
12
Database :
MEDLINE
Journal :
Vaccine
Publication Type :
Academic Journal
Accession number :
38556391
Full Text :
https://doi.org/10.1016/j.vaccine.2024.03.075